Norsk selskap for nukleærmedisin
og molekylær avbildning

Høringsutkast

EANM Guideline for RNT with 177L-labelled PSMA ligands

Dear esteemed National Delegates,

It is my pleasure to provide you attached with the EANM procedure guidelines for radionuclide therapy with 177Lu-labeled PSMA-ligands (177Lu-PSMA-RLT) written under the lead of the EANM Oncology & Theranostics Committee.

As part of the EANM guideline review process, I kindly invite you to share this draft within your national society as appropriate and get back to me with your society’s collected comments, if any, by April 26, 2019at the latest.

Logg inn for å se vedlegget.

  • Treff: 3

EANM Guidance on Validation and Qualification of Processes and Operations Involving Radiopharmaceuticals

Dear valued National Delegates,

please find enclosed the “EANM Guidance on Validation and Qualification of Processes and Operations Involving Radiopharmaceuticals ” written by the members of the EANM Radiopharmacy Committee.

According to the EANM Guideline revision process, this guideline has been revised by several EANM Committees already.

Now we would like to ask you to distribute the Guideline accordingly and send us your collected comments and suggestions by Thursday, September 15, 2016 at the latest.

As a last step in the revision process, the Guideline will then be sent to the EANM Board for final approval.

Thank you for your help and please do not hesitate to contact me in case of questions.

Best regards,

Sonja

 

Sonja Niederkofler, MA

Head of Board & Committee Services

European Association of Nuclear Medicine (EANM)

Schmalzhofgasse 26

1060 Vienna/Austria

Tel: +43-(0)1-890 44 27

Fax: +43-(0)1-890 44 27-9

E-mail: Denne e-postadressen er beskyttet mot programmer som samler e-postadresser. Du må aktivere javaskript for å kunne se den.

URL: www.eanm.org

Attachments:
FileDescriptionFile size
Download this file (9th draft validation guidelines_ND.pdf)9th draft validation guidelines_ND.pdf 631 kB
  • Treff: 1676

Mandatforslag for Clinical Audits

Mandatforslag for Clinical Audits ved nukleærmedisinske enheter ved norske sykehus

Høringsfrist: 1. mars 2011 til Denne e-postadressen er beskyttet mot programmer som samler e-postadresser. Du må aktivere javaskript for å kunne se den.

Attachments:
FileDescriptionFile size
Download this file (Clinical_Audit_EANM.pdf)Clinical_Audit_EANM.pdfClinical Audit EANM65 kB
Download this file (Mandat-forslag.pdf)Mandat-forslag.pdfMandatforslag for Clinical Audits ved nukleærmedisinske enheter ved norske sykehus29 kB
  • Treff: 422

Copyright © 2019 Norsk selskap for nukleærmedisin og molekylær avbildning
Nettredaktør: Denne e-postadressen er beskyttet mot programmer som samler e-postadresser. Du må aktivere javaskript for å kunne se den. og Denne e-postadressen er beskyttet mot programmer som samler e-postadresser. Du må aktivere javaskript for å kunne se den.. Design og programmering: Denne e-postadressen er beskyttet mot programmer som samler e-postadresser. Du må aktivere javaskript for å kunne se den.